We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
Oncolytics Biotech 在 ASCO 2026 上的数据：pelareorep 病毒激活针对突变 KRAS 的 T 细胞，用于治疗胰腺癌。了解治疗“冷”肿瘤的突破。
